| ||
Skin diseases on the rise in Baddi-Barotiwala pharmaceutical industry belt Times of India Baddi-Barotiwala belt has emerged as the pharmaceutical industry capital of India. But the introduction of new chemicals has increased the incidence of skin allergies known as industrial dermatitis. See all stories on this topic » | ||
Dementia patients worried about PBS review Sydney Morning Herald Dementia patients and their families are worried that a Pharmaceutical Benefits Scheme (PBS) review will see people lose access to much-needed medication, Alzheimer's Australia says. A review of anti-dementia drugs listed on the PBS was ordered in ... See all stories on this topic » | ||
| ||
Drug marketing code likely to be made more stringent Business Standard The Department of Pharmaceuticals has called a meeting of all industry associations and the Medical Council of India on July 18 to enforce a more stringent marketing code for drug manufacturers. The move is aimed at preventing pharmaceutical companies ... See all stories on this topic » | ||
Bayer Initiates Phase II/III Trial of New Recombinant Factor VIII Compound for ... Sacramento Bee "Bayer continues to invest in research that may provide innovative ways to advance patient care," said Pamela Cyrus, MD, Vice President and Head, U.S. Medical Affairs, Bayer HealthCare Pharmaceuticals. "This study is designed to determine the effects ... See all stories on this topic » | ||
Mumbai Set To Host 5th Annual Pharmaceutical Leadership Summit & Awards ... PR Urgent (press release) Pharmaleaders Annual Meet will debate on the theme "Brand India : Beyond Generics, Growth, Challenges & Opportunities" on 21st September. See all stories on this topic » | ||
India Free Drugs Policy Blow To 'Big Pharma' Eagle Radio The landmark project would be another massive blow to Western pharmaceutical giants who are already struggling to find a foothold in the world's second most populous country. The West's big pharmaceutical firms - or "big pharma" - have long been ... See all stories on this topic » | ||
| ||
Chinese Pharma Growth Expected to Slow Amid Reform Turbulences and ... Melodika.net (press release) Although there are growing concerns about China's economy and uncertainties about the country's healthcare reforms, the Chinese pharmaceutical industry maintained healthy growth in 2011 and the first half of 2012 as well as a generally positive outlook ... See all stories on this topic » | ||
|
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment